Insulin Glargine vs Trastuzumab

## Insulin Glargine vs Trastuzumab: Overview

This comparison examines the pharmacological differences between **Insulin Glargine** and **Trastuzumab**.

## Mechanism of Action

**Insulin Glargine**: Long-acting insulin analogue that binds insulin receptors.

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Insulin Glargine — 12-24 hours; Trastuzumab — 28 days.

## Chemical Properties

**Type**: Insulin Glargine — Protein; Trastuzumab — Antibody.